| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6241954 | Respiratory Medicine | 2014 | 9 Pages |
Abstract
The systemic exposure to the active ingredients of BDP/formoterol administered as DPI correlates inversely with age and body size suggesting that dry powder dosage regimens should be adjusted for age and body size to avoid high systemic drug levels in children.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
B.L. Chawes, M. Govoni, E. Kreiner-Møller, N.H. Vissing, P. Poorisrisak, L. Mortensen, E. Nilsson, A. Bisgaard, A. Dossing, M. Deleuran, N.L. Skytt, N. Samandari, A. Piccinno, F. Sergio, G. Ciurlia, G. Poli, D. Acerbi, D. Singh, H. Bisgaard,